Built for clinical collaboration.
Flore gives you doctor-ready reports and precision, strain-level formulations you can fold into a care plan. Microbiome data treated as medical-grade — not a consumer curiosity.
Flore acquired Sun Genomics and its microbiome technology, research, and IP. Nine years of longitudinal data — 18,392 customers, ~23,000 microbiome tests, ~40,000 personalized formulations.
- Standardized PDF report
- Strain-level resolution
- Shareable raw data & ingredient list
- Precision synbiotic — capsules or powder
What you get
Output designed to be read by a clinician, stored in a chart, and acted on.
Standardized PDF reports
Every test returns a consistent, standardized PDF a clinician can interpret at a glance and store in the patient record — the same structure across patients and across time.
Strain-level reporting
Reporting resolves to the strain level, not just genus or phylum — so what you see maps to what a formulation can actually target.
Shareable with the ordering provider
Reports, the full ingredient list, and the underlying raw data can be shared directly with the ordering provider — no black box between the sample and your clinical decision.
A provider portal, not just a PDF
Patients can upload their tests into the Flore provider portal, the portal supports provider handoffs, and providers can add clinical-note inputs to the record — so a report becomes a shared, working part of the care plan.
Precision formulations
Where indicated, a synbiotic matched to that patient’s data — drawn from 100+ ingredients, with phages available. Delivered as capsules or powder, never liquid.
Longitudinal by default
Repeat testing uses the same standardized format, so change over time is legible at a glance rather than reconstructed from mismatched panels.
How Flore fits a care plan
Four steps you can fold into an existing workflow.
Test
The patient collects a sample at home. Sequencing runs at an independent CLIA-certified, CAP-accredited laboratory.
Strain-level report
Flore returns a standardized PDF you can interpret, discuss with the patient, and store in the chart.
Personalized formulation
Where indicated, a precision synbiotic matched to that patient’s profile — a data-driven intervention you fold into the plan, not a shelf product.
Track over time
Re-test on the same standardized report to see how the microbiome moved and adjust the plan on real data.
Medical-grade data, built for your workflow
Microbiome results are treated as clinical data — formatted to move cleanly from the sample to the chart to the care plan.
Doctor-ready PDF reports
Every result returns as a standardized, clinician-readable PDF — consistent structure across patients and across repeat tests — so it drops straight into the patient record and reads the same way every time.
EMR-friendly exports
Export the report as a PDF for the chart, plus the underlying data for your own records — portable files you can attach to a patient’s EMR/EHR entry or forward to the ordering provider. No proprietary viewer required to read the report.
Share reports, ingredients & raw data
The standardized report, the full formulation ingredient list, and the patient’s underlying raw sequencing data can all be shared with the ordering provider — no black box between the sample and your clinical decision.
A provider portal, not just a file
Work in the Flore provider portal at portal.floreclinical.com: patients upload their tests, providers receive the handoff, and you add clinical-note inputs (symptoms, history, goals, concurrent care) that inform the formulation. Access is role-scoped — you see your own patients, and access is controlled and auditable.
Folds into a care plan
Test → strain-level report → personalized synbiotic where indicated → re-test on the same standardized format. Each step is designed to slot into an existing workflow rather than replace it.
Documentation for your records CRAIG: CONFIRM
Standardized reports and itemized ingredient lists give you clean documentation to keep alongside a care plan. Flore does not bill insurance and makes no reimbursement guarantee — coverage and coding are determined by the payer and the ordering clinician. Placeholder: any specific CPT/coding or superbill guidance pending Craig’s confirmed inputs.
Data privacy is HIPAA-aware and encrypted at rest. See HIPAA and our Privacy Policy. CRAIG: no third-party HIPAA certification/audit is claimed here
The science, honestly
What strain-level resolution buys you — and what the evidence does and does not yet support.
Flore reports from whole-genome (shotgun metagenomic) sequencing rather than 16S rRNA sequencing. Conceptually, 16S reads a single marker gene and generally resolves organisms to the genus level; whole-genome sequencing reads across the whole genome and can resolve to the species and strain level. Strain-level resolution is what lets a report line up with a formulation that targets specific organisms — not a broad category.
| 16S rRNA | Whole-genome (shotgun) | |
|---|---|---|
| Typical resolution | Genus level | Species / strain level |
| Reads | One marker gene | Across the whole genome |
| Maps to formulation | Broad category | Specific organisms |
Where the evidence stands. Flore is clinically informed and built on nine years of longitudinal data, but there are no published randomized controlled trials of the platform. The autism work is an open-label pilot published in mSystems — a pilot, not an RCT. Separately, an autism diagnostic model developed with the Autism Brain Foundation reported an AUC of 0.936 across 15,249 whole-genome samples. We state this plainly so you can weigh it for your practice.
Flore studies microbiome signatures across 200+ conditions under IRB oversight. Flore builds and designs the formulation and the analysis; sequencing is performed by independent accredited laboratories. Flore describes what the data shows, not proprietary methodology.
customers
microbiome tests
personalized formulations
of 18,382 customers never requested a reformulation1
within-subject symptom resolution, n=651 paired2
318 Trustpilot reviews
1 Satisfaction / tolerability measure — the share of 18,382 customers who never requested a reformulation of their personalized formula (a 4.9% complaint rate). It is not a clinical-efficacy endpoint. 2 Within-subject paired analysis of 651 patients (two microbiome tests + two symptom surveys each), published in the Flore Clinical white paper; 47.4% of tracked symptoms resolved between baseline and follow-up. Observational, self-reported, and uncontrolled — not a controlled efficacy claim. There are no published randomized controlled trials of Flore formulas.
Talk to the team
Provider access is reviewed case-by-case. Request a clinical conversation and we’ll walk you through the reports, the formulation workflow, and how Flore folds into your care plans.
Request a clinical conversation → Explore partnership & research →Email support@flore.com · Call 415-326-4743
Provider questions
Straight answers to what clinicians ask most.
Is a clinician involved in ordering and interpreting Flore?
Yes. Flore Clinical is provider-facing: licensed clinicians order the microbiome test and the personalized formulation for their patient, receive the standardized report, and add clinical-note inputs that inform the formula. It is designed for supervised care, not self-directed use.
What does the provider portal do?
The provider portal at portal.floreclinical.com is your working surface: patients upload their tests, you receive the handoff, add clinical notes, order formulations, and track outcomes longitudinally. Access is role-scoped and auditable — you see your own patients.
Can I export reports into my EMR/EHR?
Reports are standardized PDFs you can download and attach to a patient’s EMR/EHR entry, and the underlying data is available for your own records. There is no proprietary viewer required to read the report. Flore does not currently offer a direct HL7/FHIR EMR integration; export is file-based.
Can I share the raw data and ingredient list with my patient or another provider?
Yes. The standardized report, the full formulation ingredient list, and the patient’s underlying raw sequencing data can all be shared with the ordering provider and the patient — nothing about what’s in the formula or what the sequencing found is hidden from you.
How does Flore fit into a care plan?
Test → strain-level report you store in the chart → a precision synbiotic where indicated → re-test on the same standardized format to see how the microbiome moved and adjust. Each step slots into an existing workflow rather than replacing it. Formulas are structure/function supplements — not intended to diagnose, treat, cure, or prevent any disease.
What about reimbursement and documentation?
Standardized reports and itemized ingredient lists give you clean documentation to keep with a care plan. Flore does not bill insurance and makes no reimbursement guarantee — coverage and coding are determined by the payer and the ordering clinician.
What evidence stands behind Flore, and what are its limits?
Flore is built on nine years of longitudinal, real-world data. Across 18,382 customers, 95.1% never requested a reformulation (a tolerability/satisfaction measure, not efficacy). A within-subject paired analysis of 651 patients found 47.4% of tracked symptoms resolved between baseline and follow-up — observational, self-reported, and uncontrolled. There are no published randomized controlled trials; the autism work is an open-label pilot published in mSystems, a pilot rather than an RCT.